𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Wilms' tumor: Reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology

✍ Scribed by Robert L. Tobin; James Fontanesi; Larry E. Kun; Diane L. Fairclough; H.Omar Hustu; William J. Pao; Edwin C. Douglass; Judith Wilimas; A.P. Mahesh Kumar; Jesse J. Jenkins


Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
715 KB
Volume
19
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Doxorubicin for favorable histology, Sta
✍ Norman E. Breslow; San-San Ou; J. Bruce Beckwith; Gerald M. Haase; John A. Kalap πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 1 views

## Abstract ## BACKGROUND After randomized trials in the 1980s, doxorubicin (DOX) was added to dactinomycin plus vincristine as standard chemotherapy for patients who had Stage III Wilms tumor (WT) of favorable histology (FH). Double‐agent chemotherapy was retained for patients with Stage II disea

Treatment of children with stage IV favo
✍ Green, Daniel M.; Breslow, Norman E.; Evans, Ilonka; Moksness, Jami; D'Angio, Gi πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 491 KB πŸ‘ 2 views

The purpose of this study was to evaluate the effect of the sequential addition of doxorubicin and cyclophosphamide to the combination of vincristine and actinomycin D o n the relapse-free survival of children with stage IV/favorable histology Wilms tumor. We reviewed the clinical courses of all ran